Pharmaceutical - New Zealand

Filter

Current filters:

New Zealand

Popular Filters

1 to 25 of 26 results

Major step forward for multiple sclerosis treatment in New Zealand

13-10-2014

Funding for newer and more effective multiple sclerosis (MS) treatments has been approved by PHARMAC,…

Biogen IdecCopaxoneFinancialGilenyaHealthcareNeurologicalNew ZealandNovartisPharmaceuticalTeva Pharmaceutcal IndustriesTysabri

New Zealand approval of Novartis multiproduct proposal

10-10-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

NeurologicalNew ZealandOncologyPharmaceuticalRegulationRespiratory and Pulmonary

Nicox partners with OptiMed for distribution of its portfolio in Australia and New Zealand

Nicox partners with OptiMed for distribution of its portfolio in Australia and New Zealand

09-10-2014

International ophthalmic company Nicox has entered into an exclusive licensing agreement with Australian…

AdenoPlusAustraliaLicensingMedImmuneNew ZealandNicOxOphthalmicsPharmaceuticalXailin

Bayer’s Jadelle to be listed in New Zealand

Bayer’s Jadelle to be listed in New Zealand

26-09-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

BayerJadelleMarkets & MarketingNew ZealandPharmaceuticalPricingReproductiveWomen's Health

New Zealand to fund Vidaza and Revlimid

New Zealand to fund Vidaza and Revlimid

13-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC says it has approved a proposal for funding…

Celgene Corp.FinancialHealthcareNew ZealandPharmaceuticalPricingRevlimidVidaza

Medicines New Zealand updates its code of practice to cover social media

Medicines New Zealand updates its code of practice to cover social media

13-08-2014

New Zealand's pharmaceutical industry association, Medicines New Zealand, has updated its Code of Practice…

New ZealandPharmaceuticalPharmaceuticals policyPharmacologyRegulation

Multiple sclerosis treatments funding proposal in New Zealand

Multiple sclerosis treatments funding proposal in New Zealand

07-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on a funding proposal involving…

Biogen IdecFinancialGilenyaNeurologicalNew ZealandNovartisPharmaceuticalTysabri

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

15-07-2014

New Zealand Pharmaceutical Management Agency PHARMAC has awarded a tender to Netherlands-headquartered…

Antibiotics and Infectious diseasesFinancialHealthcareNew ZealandNorginePharmaceuticalXifaxan

New Zealand proposes contestable fund for medicines for rare disorders

New Zealand proposes contestable fund for medicines for rare disorders

09-07-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC will be running a commercial process to fund…

FinancialNew ZealandPharmaceuticalRare diseasesRegulation

Changes to the funding access criteria for some vaccines in New Zealand

Changes to the funding access criteria for some vaccines in New Zealand

09-06-2014

New Zealand’s Pharmaceutical Management Agency, PHARMAC, this morning announced changes to the funding…

FinancialHealthcareNew ZealandPharmaceuticalVaccines

New treatment funded for severe gout in New Zealand

21-05-2014

Patients with severe gout will soon have a new treatment option as New Zealand’s Pharmaceutical Management…

AdenuricAnti-Arthritics/RheumaticsfebuxostatFinancialMenariniNew ZealandPharmaceuticalRegulation

Promoting competition key to improving patients’ access to high cost medicines, says PHARMAC

Promoting competition key to improving patients’ access to high cost medicines, says PHARMAC

08-04-2014

New Zealand’s Pharmaceutical Management Agency, PHARMAC, has announced its intention to test out a…

Asia-PacificFinancialHealthcareNew ZealandPharmaceuticalRare diseases

Funding restrictions for rituximab and eltrombopag widened in New Zealand

Funding restrictions for rituximab and eltrombopag widened in New Zealand

20-02-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of proposals to widen…

Asia-PacificeltrombopagFinancialGlaxoSmithKlineHealthcareImmunologicalsNew ZealandPharmaceuticalrituximabRoche

Citing “unreasonable price,” New Zealand declines eculizumab funding

Citing “unreasonable price,” New Zealand declines eculizumab funding

13-12-2013

New Zealand’s Pharmaceutical Management Agency PHARMAC has declined the funding application for eculizumab…

Alexion PharmaceuticalsAsia-PacificeculizumabGlaxoSmithKlineHematologyNew ZealandPharmaceuticalPricingRare diseasesRevoladeSoliris

New Zealand funding plans for Tarceva and Revolade

New Zealand funding plans for Tarceva and Revolade

09-12-2013

Following a consultation, New Zealand’s Pharmaceutical Management Agency PHARMAC said this morning…

Asia-PacificGlaxoSmithKlineHematologyNew ZealandOncologyPharmaceuticalPricingRegulationRevoladeRocheTarceva

Medicine prescribing in New Zealand hits new high as PHARMAC role expands

07-12-2013

New Zealanders have gained greater access to medicines in 2013, and record numbers of New Zealanders…

Asia-PacificHealthcareNew ZealandPharmaceuticalRegulation

New Zealand views access to sugammadex and atomoxetine and baclofen injection funding

02-12-2013

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on the following proposals…

Asia-PacificBridionEli LillyLioresal IntrathecalMerck & CoNeurologicalNew ZealandPharmaceuticalRegulationStrattera

Establishing a common regulatory framework for Australia and New Zealand

13-11-2013

As part of transitioning to an Australia New Zealand Therapeutic Products Agency, Australia’s Therapeutic…

Asia-PacificHealthcareNew ZealandPharmaceuticalRegulation

New Zealand govt “tinkers around R&D tax deductibility,” says Labour

09-11-2013

New Zealand’s National Party Government’s call for feedback to resolve problems around the tax deductibility…

Asia-PacificFinancialNew ZealandPharmaceuticalPoliticsResearch

New Zealand views addition of rotavirus, varicella vaccines to national immunization schedule

07-11-2013

A vaccine for the gastric infection rotavirus and protection from varicella for the most vulnerable people…

FinancialHealthcareNew ZealandPfizerPharmaceuticalPrevenarVaccines

1 to 25 of 26 results

Parexel

Parexel

Back to top